|
|
Volumn 48, Issue SUPPL. 1, 2001, Pages 17-28
|
|
Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIBIOTIC AGENT;
AZTREONAM;
CEFACLOR;
CEFADROXIL;
CEFALEXIN;
CEFAMANDOLE;
CEFAZOLIN;
CEFEPIME;
CEFIXIME;
CEFODIZIME;
CEFOPERAZONE;
CEFOTAXIME;
CEFOTETAN;
CEFOXITIN;
CEFPIROME;
CEFPODOXIME;
CEFPROZIL;
CEFRADINE;
CEFTAZIDIME;
CEFTIBUTEN;
CEFTRIAXONE;
CEFUROXIME;
DEMECLOCYCLINE;
IMIPENEM;
MEROPENEM;
PIPERACILLIN PLUS TAZOBACTAM;
UNINDEXED DRUG;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
CLASSIFICATION;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG PROTEIN BINDING;
DRUG RESPONSE;
HUMAN;
IN VITRO STUDY;
MEDICAL SOCIETY;
METHODOLOGY;
MINIMUM INHIBITORY CONCENTRATION;
PARAMETER;
PRACTICE GUIDELINE;
|
|
EID: 0034927287
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/48.suppl_1.17 Document Type: Article |
|
Times cited : (162)
|
|
References (10)
|
